 Pacira Biosciences Inc NASDAQ:PCRXs stock price reached a new 52-week high on Monday after HC Wainwright raised their price target on the stock from 68.00 to 70.00. HC Wainwright currently has a buy rating on the stock. Pacira Biosciences traded as high as 60.60 and last traded at 59.95, with a volume of 21163 shares ... 